Dow Jones futures rose slightly Thursday evening, along with S&P 500 futures and Nasdaq futures, after U.S. markets were closed for the Thanksgiving Day holiday. Apple, Microsoft and Tesla are in the news.
The stock market rally was positive for a second straight session on Wednesday. Fed officials see slower rate hikes coming “soon,” according to Fed minutes from the November meeting released Wednesday afternoon.
The Nasdaq led, buoyed by a rebounding Tesla (TSLA). The major indexes are all up solidly so far in this holiday-shortened week. But a longer holiday for the market rally could be constructive.
Investors should be cautious about adding exposure given key technical resistance and notable economic reports up ahead.
However, Dexcom (DXCM), UnitedHealth (UNH), Neurocrine Biosciences (NBIX), Medpace Holdings (MEDP) and Shockwave Medical (SWAV) are five health care stocks showing interesting action.
DXCM stock and Neurocrine Biosciences are on IBD Leaderboard, with MEDP stock on the Leaderboard watchlist. NBIX stock and Medpace are on the IBD 50.
Tesla FSD Beta Release
Tesla CEO Elon Musk tweeted Thursday that Full Self-Driving Beta is now available to any FSD owners in North America who request it.
That could allow Tesla to recognize more deferred revenue from FSD.
Despite its name, Full Self-Driving does not offer full self-driving, but is a Level 2 driver assist system. The National Highway Traffic Safety Administration is investigating Autopilot and FSD safety. The Justice Department reportedly is conducting a criminal probe of Tesla’s self-driving claims.
Tesla stock jumped 7.8% to 183.20 on Wednesday, rebounding from Tuesday’s bear market lows as Citigroup upgraded the EV giant from a sell to a hold. TSLA stock is still down 19.5% so far this month and has roughly halved in 2022.
Dow Stock Deal News
In Dow Jones stock news, Apple (AAPL) reportedly is interested in buying U.K. soccer giant Manchester United (MANU). The Federal Trade Commission may try to block the Microsoft (MSFT) deal to buy Activision Blizzard (ATVI) for nearly $69…